- AU$32.78bn
- AU$34.67bn
- AU$10.83bn
Australia's Sigma in early talks to acquire British pharmacy Boots (updated)
Australia's Sigma Healthcare confirms early-stage talks to buy UK's Boots
UK's Boots in talks for $10 billion sale as owners plan to scrap IPO plans, FT reports
Brief: Boots In Talks Over $10 Billion Sale As Owners Look To Ditch IPO Plan - FT
Morningstar says Australia's Sigma Healthcare stock moderately overvalued
Australia's Sigma Healthcare hits two-month high on UK market expansion, sales growth
Brief: Sigma Healthcare Signs Mou With Greenlight To Enter UK Market
Australia's Sigma Healthcare rises after Jefferies upgrades to 'buy' on growth prospects
Jefferies upgrades Australia's Sigma Healthcare to 'buy' on growth prospects
Brief: Sigma Healthcare Announces Interim Dividend Of 2 AU Cents Per Share
Brief: Sigma Healthcare Announces Trading In First Seven Weeks Of H2 Has Seen Growth Momentum Continue
Brief: Pharmx Technologies Enters Multi-Year Strategic Alliance With Sigma
Brief: Sigma Healthcare Appoints Richard Murray As CFO
Brief: Sigma Healthcare Says Mark Davis Will Step Down From Role Of Group CFO
Brief: Sigma Healthcare Says FY26 Started Strongly
Bell Potter begins Sigma Healthcare coverage with discounted PT
Australia's HMC Capital drops on cutting earnings forecast (updated)
Australia's Sigma Healthcare falls to 1-month low; UBS retains 'neutral'
Brief: Sigma Healthcare Says 9M Normalised EBIT Growth Broadly Consistent With 1H Fy25